FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Fludarabine Phosphate Injection
Status: Currently in Shortage
»Date first posted: 05/06/2022
»Therapeutic Categories: Oncology

Expand all

Fresenius Kabi USA, LLC (New 05/06/2022)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
50 mg per 2 mL (25 mg per mL), Single dose vial, PF (NDC: 63323-192-02) Backordered. Next release mid-late June 2022. Check wholesaler inventory Demand increase

Teva Pharmaceuticals (Reverified 05/19/2022)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Lyophilized Powder for Injection, 50 mg /vial (NDC 45963-0609-55, 1 Single-Dose Vial) On backorder. Estimated duration: May 2022 Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English